Decentralized Trials: FDA Final Guidance Eliminates Need For Local Provider Activity Tracking

 
• By Sue Sutter
  
Health care provider
Local, qualified health care providers may perform certain activities in clinical trials with decentralized elements. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D